Inventor · disambiguated record
Detlef Grawe
Also filed as: GRAWE DETLEF
11 granted patents·6 pending applications·87 citations·filing 1997–2013
87Inventor score
Top patents by PatentIndex Score
17 records- 0188US6902741B1Laminates containing an active substance transdermal systemJENAPHARM GMBH·Filed 2000·Granted Jun 7, 2005·37 cites·15 claims
- 0271US7799770B2Solid body forms of mesoprogestin 11β-{4E-(hydroxyiminomethyl)-phenyl}-17α methoxymethyl-17β-methoxy-estra-4,9-dien-3-oneBAYER SCHERING PHARMA AG·Filed 2001·Granted Sep 21, 2010·6 cites·14 claims
- 0369US7192942B2Process for production of crystals of 11μ-benzaldoxim-estra-4,9-diene derivatives, crystals obtained thereby and pharmaceutical preparations containing themSCHERING AG·Filed 2003·Granted Mar 20, 2007·6 cites·23 claims
- 0467US6063404ABioadhesive tabletJENAPHARM GMBH·Filed 1998·Granted May 16, 2000·32 cites·15 claims
- 0562US7148212B2Process for production of steroid crystals, steroid crystals obtained thereby and pharmaceutical preparations containing themSCHERING AG·Filed 2003·Granted Dec 12, 2006·2 cites·17 claims
- 0647US9173843B2Crystalline active ingredient microparticles, method for producing the same and use thereof in drugsGRAWE DETLEF·Filed 2009·Granted Nov 3, 2015·0 cites·27 claims
- 0747US2003215516A1Process for production of crystals of a medicinally effective ingredient, crystals obtained thereby and pharmaceutical preparations containing themFiled 2003·Application pending·0 cites
- 0847US2016271145A1Method for enlarging the particle size of crystalline microparticles of active substanceJESALIS PHARMA GMBH·Filed 2013·Application pending·0 cites
- 0946US2002119103A1Homogeneous preformulations containing high concentration of steroids, for producing low-dose solid and semi-solid pharmaceutical preparationsFiled 2001·Application pending·0 cites
- 1044US9095783B2Arrangement and method for producing high-purity crystalsGRAWE DETLEF·Filed 2009·Granted Aug 4, 2015·0 cites·21 claims
- 1143US2009054387A1Method for preparing 4-[17beta-methoxy-17alpha-methoxymethyl-3-oxestra-4,9-dien-11beta-yl]benzaldehyde (E)-oxime (asoprisnil)GRAWE DETLEF·Filed 2007·Application pending·0 cites
- 1243US2013165421A14-[17beta-methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11-beta-yl]benzaldehyde (e)-oxime (asoprisnil)Bayer Pharma AG·Filed 2012·Application pending·0 cites
- 1339US9211485B2Method for producing crystalline active ingredient particlesGRAWE DETLEF·Filed 2011·Granted Dec 15, 2015·0 cites·7 claims
- 1438US8324412B2Method for preparing 4-[17β-methoxy-17α-methoxymethyl-3-oxoestra-4,9-dien-11β-yl]benzaldehyde (E)-oxime (asoprisnil)GRAWE DETLEF·Filed 2011·Granted Dec 4, 2012·0 cites·18 claims
- 1538US6974885B2Method for isolating pharmaceutically exploitable etidronate disodiumSCHERING AG·Filed 2001·Granted Dec 13, 2005·0 cites·12 claims
- 1637US2003215517A1Process for production of crystals of an adjuvant substance, crystals obtained thereby and pharmaceutical preparations containing themFiled 2003·Application pending·0 cites
- 1734US6290931B1Homogeneous preformulations containing high concentrations of steroids, for producing low-dose solid and semi-solid pharmaceutical preparationsJENAPHARM GMBH·Filed 1997·Granted Sep 18, 2001·4 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →